, Volume 78, Issue 9, pp 891–891 | Cite as

Correction to: Inhibition of Tissue Factor Pathway Inhibitor (TFPI) as a Treatment for Haemophilia: Rationale with Focus on Concizumab

  • Pratima Chowdary

1 Correction to: Drugs

Figure 1

The legend, which reads

Mechanisms of action of monoclonal antibodies against tissue factor pathway inhibitor (TFPI)

Should read

TFPI mechanism of action and inhibition by anti-TFPI antibodies. a Tissue factor (TF) based initiation of coagulation and generation of FXa by the extrinsic tenase complex (FVIIa.TF.FX). b Inhibition of FXa and FVIIa by TFPI. c Binding of the different Kunitz (K) domains by the various anti-TFPI antibodies.

The original article has been corrected.

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free HospitalLondonUK

Personalised recommendations